Skip to content

Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis

Clinical Application of Continuous Monitoring Data for the Pulse Rate, Exercise, and Calorie Intake by Wearable Activity Trackers in the Patients With Thyrotoxicosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03009357
Acronym
AT-thyro
Enrollment
40
Registered
2017-01-04
Start date
2016-11-30
Completion date
2017-08-31
Last updated
2018-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves Disease, Thyroiditis, Thyrotoxicosis

Keywords

wearable activity tracker, thyrotoxicosis

Brief summary

The study is a single-center prospective cohort study of clinical application of continuously monitored data by wearable activity trackers in the patients with thyrotoxicosis. The purpose of the study is to evaluate the association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic status along with the treatment.

Detailed description

Activity trackers to be used: Fitbit Charge HR (TM) Data which ware provided by Fitbit app (TM) will be analyzed in this study.

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing newly developed or recurrent thyrotoxicosis who are treated and followed-up in Seoul National University Bundang Hospital * Patients who can use wearable activity trackers and smartphone applications * In case of Graves' disease, patients who will treated by anti-thyroid drugs

Exclusion criteria

* Patients who have thyrotoxic periodic paralysis * In case of Graves' disease, patients who will treated by radioactive iodine therapy or thyroidectomy * Patients who have thyrotoxicosis due to toxic nodular disease

Design outcomes

Primary

MeasureTime frame
Association between parameters of pulse rate, activity, and sleep from wearable activity trackers and the thyrotoxic statuscontinuous monitoring through the study period (average 3 months)

Secondary

MeasureTime frame
Association between user-generated dietary parameters on mobile applications and the thyrotoxic statuscontinuous monitoring through the study period (average 3 months)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026